5-methoxytryptamine has been researched along with Hepatocellular Carcinoma in 1 studies
5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heath-Pagliuso, S | 1 |
| Rogers, WJ | 1 |
| Tullis, K | 1 |
| Seidel, SD | 1 |
| Cenijn, PH | 1 |
| Brouwer, A | 1 |
| Denison, MS | 1 |
1 other study available for 5-methoxytryptamine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Activation of the Ah receptor by tryptophan and tryptophan metabolites.
Topics: 5-Methoxytryptamine; Animals; Binding, Competitive; Carcinoma, Hepatocellular; Cell Nucleus; Cytochr | 1998 |